Navigation Links
Molecular Devices, LLC Introduces SoftMax Pro® 6 Microplate Data Acquisition and Analysis Software With Powerful New Data Analysis and Reporting Features
Date:10/27/2011

SUNNYVALE, Calif., Oct. 27, 2011 /PRNewswire/ -- Today, Molecular Devices, LLC, a leader in bioanalytical systems for drug discovery, life science research, and bioassay/test development, today announced the launch of SoftMax® Pro 6 Microplate Data and Analysis Software. SoftMax Pro software is the industry standard with superior data analysis capabilities critical to researchers in R&D, drug manufacturing, quality control, and analysis in the biotech and pharmaceutical industries.

(Logo:  http://photos.prnewswire.com/prnh/20100406/SF82092LOGO)

SoftMax Pro is a robust, all-in-one software package. With the new data analysis features such as 3-D graphing, plate cloning, side-by-side comparison view, and Syntax Helper, it's easy to do all your data analysis without the need to export your data. Additionally, the new all-inclusive reporting removes the need to copy and paste your graphs or tables into text formatted documents. These new features help eliminate the need for additional software.

Commenting on the launch of SoftMax Pro 6 software, Mikey Kindler, BioResearch Director, Molecular Devices, noted, "The release of SoftMax® Pro 6 Data Acquisition and Analysis Software demonstrates our commitment to world-class software development. Not only did we redesign the user interface with significantly expanded data analysis features, but also this new platform is designed with expansion in mind, allowing us to quickly address future user needs and market requirements."

Since its introduction, SoftMax Pro software has set the standard for data acquisition and analysis in the microplate reader industry paired with the award-winning microplate reader offering. SoftMax Pro® 6 Software works with Molecular Devices' SpectraMax® absorbance readers, Gemini™ XPS and EM fluorescence readers, SpectraMax Paradigm® platform, M-series, and FilterMax Series microplate readers.

Designed exclusively for the unique requirements and preferences of microplate instrumentation, SoftMax Pro 6 software offers a clean interface with easy access to the most common tasks based on Microsoft's ribbon interface. SoftMax Pro 6 software expands the data analysis features even further with new Syntax Helper, additional curve fits, 3-D graphing, side-by-side data comparison, and plate cloning. SoftMax Pro 6 also enhances the customization tools with all-inclusive reporting containing live mini-graphs and tables, image display, and layout flexibility. The new SoftMax Pro 6 requires minimal training for everyone in your lab and will maximize your productivity with the expanded feature offering.

About Molecular Devices, LLC

At Molecular Devices we have one focus—our customers. Whether a long-time user, recent adopter, or prospective customer, your needs fuel our actions. We hire creative, best-in-class people to design, manufacture, and commercialize analytical instruments, software, and assays as well as provide dedicated follow-on support. Understanding your laboratory workflow is our top priority, and we direct product development toward solving your unique issues. Our instruments offer a full spectrum of detection technologies and meet all throughput needs—from dedicated, single-readout devices to multi-readout systems. Our goal is to deliver highly relevant analytical products to detect biology, decode data, and drive discovery. With headquarters in Silicon Valley and offices around the globe, we support and enrich efforts of the international BioResearch, BioPharma, and BioTesting communities. Visit us today at www.MolecularDevices.com.

Molecular Devices products are for Research Use Only. Not for use in diagnostic procedures.

The trademarks mentioned herein are the property of Molecular Devices, LLC, or their respective owners.

© 2011. Molecular Devices, LLC


'/>"/>
SOURCE Molecular Devices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. BD Announces FDA 510(K) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to Surgery
2. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
3. Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
4. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
5. Tapestry Pharmaceuticals Presents Data on TPI 287 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
6. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
7. Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH)
8. Study of Pathwork Diagnostics Tissue of Origin Test Published in the Journal of Molecular Diagnostics: Investigates Test Reproducibility in Multiple Labs to Determine Primary Tumor in Cancer Cases
9. Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway
10. Molecular Biometrics Hires Denny Sakkas, PhD Renowned Yale Embryologist and International Thought-Leader, as Chief Scientific Officer; Opening U.S. Research Facility
11. Molecular Therapy Succeeds in Preventing Craniofacial Birth Defect in Mice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... , June 23, 2016 Bracket , ... launch its next generation clinical outcomes platform, Bracket eCOA (SM) ... held on June 26 – 30, 2016 in ... first electronic Clinical Outcome Assessment product of its kind to ... #715. Bracket eCOA 6.0 is a flexible platform ...
(Date:6/23/2016)... , June 23, 2016 Revolutionary ... Oticon , industry leaders in advanced audiology ... of Oticon Opn ™, the world,s first internet ... possibilities for IoT devices.      (Photo: ... introduces a number of ,world firsts,: , ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... ... ... Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair ... hour by 2020 and then adjusting it yearly to increase at the same rate as ... the wage floor does not erode again, and make future increases more predictable. , The ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):